On this page
The Onchocerciasis Elimination Mapping (OEM) Project Phase I, supported by the Bill & Melinda Gates Foundation, has been developing a template of actions that will lead to a standardised approach in accomplishing OEM in the remaining hypoendemic areas by 2020.
By building the foundations and preparatory work for developing, operationalising and the scaling up of OEM protocols, a standardised mapping protocol and implementation approach is evolving. One of the key objectives and actions towards achieving this is piloting the WHO Onchocerciasis Technical Advisory Sub-group (OTS) protocol in selected districts. As part of the selection process, our analysis sought to include ivermectin naïve districts, where we might expect to find a positive signal using OV16, and districts where loa loa was not found to be co-endemic.
A further consideration to country and district choice has been to avoid overlap with any current research being conducted by the taskforce. With these variables in mind, we have, in consultation with ESPEN, selected districts in Ghana, Nigeria and Mozambique to operationalise the protocol, and conduct the pilot. From these pilots we hope to ensure that the lessons learned are transcribed into a standardised implementation approach, which can then ensure that the subsequent Phase II will secure funding and ensure that the remaining hypoendemic areas receive the appropriate actions to eliminate the disease.
Read the report (pdf)
Update on the Onchocerciasis Elimination Mapping (OEM) Project
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.